Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Year: 1995
Type: article
Source: PubMed
Authors: G H Barbier, U R Shettigar, D O Appunn
Institution: Bay Pines VA Healthcare System
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: esmolol, ultra-short-acting beta-blocker, intravenous beta-blockers, antihypertensive therapy, tachyarrhythmias, atrial fibrillation, supraventricular tachycardia, unstable angina, myocardial infarction, congestive heart failure, chronic obstructive pulmonary disease, hypotension, dose titration, adverse effects
Open Access status: closed
OpenAlex ID: W65826295
